Enteric Disease Testing Market 2022-2028

Description

List of Tables

Title:Global Enteric Disease Testing Market Size, Share & Trends Analysis Report, By Pathogen Tested (E. coli, Salmonella, Campylobacter, and Listeria), By Technology (Traditional, Rapid, Polymerase chain reaction (PCR), Immunoassay, and Chromatography & Spectrometry), By End-User (Water and Food), Forecast Period (2022-2028).

The global enteric disease testing market is anticipated to grow at a CAGR of 3.2% during the forecast period. The growing number of enteric disease cases among children is leading to increasing demand for enteric disease testing. The weak immune system of children is boosting the enteric disease testing market during the forecast period as due to the weak immune system, children, get affected by enteric diseases easily as compared to others. According to the United Nations, International Children's Emergency Fund (UNICEF) and World Health Organization (WHO) diarrhea are one of the leading killers of children, which causes around 8% of mortalities among children under the age of 5. Every year it kills around 525,000 children and around 1.7 billion cases of children's diarrhea disease are reported. This, in turn, leads to increasing demand for enteric disease testing.

The global enteric disease testing market is segmented based on pathogen tested, technology and end-user. Based on the pathogen tested, the market is segmented into E. coli, salmonella, campylobacter, and listeria. Based on technology, the market is segmented into the traditional, rapid, polymerase chain reaction (PCR), immunoassay, chromatography & spectrometry. Based on end-use, the market is segmented into water and food. The above-mentioned segments can be customized as per the requirements.

The global enteric disease testing market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America region is anticipated to hold a significant share in the enteric disease testing market, owing to the increasing cases of enteric diseases in the region is boosting the demand for the enteric disease testing market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 5,700 infections of Salmonella Typhi occur among people in the US each year, and around 620 peoples are hospitalized also around 110 cases of botulism is reported annually in the US around 25% of these cases are foodborne botulism.

The major companies serving the global enteric disease testing market include Bio-Rad Laboratories, Inc., Abbott Laboratories, Quest Diagnostics, BioMerieux SA, and Meridian Bioscience, Inc. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021 SGS SA opened a food testing laboratory in Papua New Guinea which will offer internationally recognized quality testing to the food manufacturing, hospitality, and retail market segments.

Research Methodology

The market study of the global enteric disease testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Enteric Disease Testing Market Research and Analysis by Pathogen Tested
Global Enteric Disease Testing Market Research and Analysis by Technology
Global Enteric Disease Testing Market Research and Analysis by End-User

The Report Covers:

Comprehensive research methodology of the global enteric disease testing market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global enteric disease testing market.
Insights about market determinants that are stimulating the global enteric disease testing market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026840

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Recovery Scenario of Global Enteric Disease Testing Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Bio-Rad Laboratories, Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Abbott Laboratories
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Quest Diagnostics
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
- 3.1.4. Biomerieux SA
  - 3.1.4.1. Overview
  - 3.1.4.2. Financial Analysis
  - 3.1.4.3. SWOT Analysis
  - 3.1.4.4. Recent Developments
- 3.1.5. Meridian Bioscience Inc.
  - 3.1.5.1. Overview
  - 3.1.5.2. Financial Analysis
  - 3.1.5.3. SWOT Analysis
  - 3.1.5.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Enteric Disease Testing Market by Pathogen Tested
- 4.1.1. E. coli
- 4.1.2. Salmonella
- 4.1.3. Campylobacter
- 4.1.4. Listeria
- 4.1.5. Others
4.2. Global Enteric Disease Testing Market by Technology
- 4.2.1. Traditional
- 4.2.2. Rapid
- 4.2.3. Polymerase chain reaction (PCR)
- 4.2.4. Immunoassay
- 4.2.5. Chromatography & spectrometry
4.3. Global Enteric Disease Testing Market by End User
- 4.3.1. Water
- 4.3.2. Food
  - 4.3.2.1. Meat, Poultry, and Seafood
  - 4.3.2.2. Dairy Products
  - 4.3.2.3. Processed Food
  - 4.3.2.4. Fruits & Vegetables
  - 4.3.2.5. Other Food Products (Nuts, Herbs & Spices, and Cereals & Grains)

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. AsureQuality Ltd.
6.2. Becton, Dickinson and Company (BD)
6.3. Bio-Rad Laboratories, Inc.
6.4. Certified Laboratories Inc.
6.5. Coris BioConcept SPRL
6.6. Eurofins Scientific
6.7. Hardy Diagnostics
6.8. Intertek Group plc
6.9. Merck Group (Merck KGaA)
6.10. Merieux NutriSciences Corp
6.11. Neogen Corp
6.12. Nova Biologicals
6.13. PerkinElmer, Inc.
6.14. Quest Diagnostics
6.15. Romer Labs Division Holding GmbH
6.16. SGS SA
6.17. Symbio Laboratories
6.18. TUV SUD